-

17EdTech Shareholder Notice: Robbins LLP is Investigating 17 Education & Technology Group Inc. (YQ) on Behalf of Shareholders

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP is investigating 17 Education & Technology Group Inc. (NASDAQ: YQ) and its officers and directors to determine whether they breached fiduciary duties or violated securities laws in connection with the Company's December 2020 initial public offering ("IPO"), 17EdTech purports to be a leading education technology company that provides K-12 education services in the People's Republic of China ("PRC").

If you would like more information about our investigation of 17 Education & Technology Group Inc.'s misconduct, click here.

What is this Case About: According to the class action complaint filed against the Company and various defendants, 17EdTech held its IPO on December 4, 2020, issuing approximately 27,400,000 American Depository Shares ("ADSs") at $10.50 per ADS. Just a year later, 17EdTech ceased its core offering of tutoring services for students K-12. PRC authorities have been targeting private education and tutoring companies since at least February 2019, when Chinese authorities publicly proposed a 2018-2022 plan for modernizing Chinese education, which included restricting foreign investment in education and reducing the burden of education and training. On July 23, 2021, Chinese authorities formally revealed to the public continued regulations banning after-school tutoring companies that teach the school curriculum from making profits, raising capital, or going public.

The offering documents supporting 17EdTech's IPO failed to disclose the Company's K-12 tutoring services would be shut down in a year's time, effectively curtailing and/or ending 17EdTech's core business. As the Company disclosed the impact of the ban on after-school tutoring companies, 17EdTech's stock spiraled downwards. Since the IPO, as it disclosed material adverse facts that it had omitted from the offering documents, 17EdTech's stock has declined approximately 85%.

Next Steps: If you acquired shares of 17EdTech pursuant to the Company's IPO, you have until September 19, 2022, to ask the court to appoint you lead plaintiff for the class. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Contact us to learn more:

Aaron Dumas
(800) 350-6003
adumas@robbinsllp.com
Shareholder Information Form

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. To be notified if a class action against 17 Education & Technology Group Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Aaron Dumas
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Robbins LLP

NASDAQ:YQ

Release Summary
17EdTech (YQ) may have misled investors regarding the viability of its long-term business prospects
Release Versions
$Cashtags

Contacts

Aaron Dumas
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Social Media Profiles
More News From Robbins LLP

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the POMDoctor Ltd. Securities Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired POMDoctor, Ltd. (NASDAQ: POM) securities between October 9, 2025 and December 11, 2025. POMDoctor claims to be "a leading online medical services platform for chronic diseases in China." For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Alleg...

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the Inovio Pharmaceuticals, Inc. Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all persons that purchased or otherwise acquired Inovio Pharmaceuticals, Inc. (NASDAQ: INO) securities between October 10, 2023 and December 26, 2025. Inovio is a biotechnology company focused on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with, inter alia, human papillomavirus (“HPV”). For more information, submit a...

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the Masonite International Corporation (k/n/a Owens Corning's Doors) Securities Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all sellers of Masonite International Corporation (NYSE: DOOR) (k/n/a Owens Corning's Doors) common stock between June 5, 2023 and February 8, 2024. Masonite is a leading global designer, manufacturer, marketer, and distributor of interior and exterior doors and door solutions for the residential and non-residential building construction markets’ new construction and repair, renovation and re...
Back to Newsroom